Mechanisms of the development of androgen independence in prostate cancer Alan SoMartin GleaveColleen Nelson Topic Paper 27 January 2005 Pages: 1 - 9
Chemotherapy for androgen-independent prostate cancer Daniel P. Petrylak Topic Paper 01 February 2005 Pages: 10 - 13
The role of bisphosphonates in hormone-refractory prostate cancer Fred SaadPierre KarakiewiczPaul Perrotte Topic Paper 22 January 2005 Pages: 14 - 18
Rationale for the development and current status of calcitriol in androgen-independent prostate cancer Tomasz M. BeerAnne MyrthueKristine M. Eilers Topic Paper 25 January 2005 Pages: 28 - 32
Targeting Bcl-2 with oblimersen for patients with hormone refractory prostate cancer Kim N. Chi Topic Paper 19 February 2005 Pages: 33 - 37
Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer Martin GleaveHideaki Miyake Topic Paper 26 January 2005 Pages: 38 - 46
Immunotherapy with autologous antigen presenting cells for the treatment of androgen independent prostate cancer Paul F. SchellhammerRobert M. Hershberg Topic Paper 13 January 2005 Pages: 47 - 49
Impact of tumor size on the long-term survival of patients with early stage renal cell cancer M. KuczykG. WegenerA. Stenzl Free Paper 24 February 2005 Pages: 50 - 54
Sacral colpopexy using mersilene mesh in the treatment of vaginal vault prolapse Jerry LimbKay WoodSherif Aboseif Free Paper 11 November 2004 Pages: 55 - 60
Clinical characterization of the prostatitis patient in Italy: a prospective urology outpatient study Michelangelo RizzoFederico MarchettiJ. Curtis Nickel Free Paper 17 November 2004 Pages: 61 - 66